ORX:STO
Orexo AB
0,98 SEK
arrow_downward
-1,70%(-0,017) 1D
20 ნოე, 17:29:34 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
345,30 მლნ.
Avg. vol.
785,30 ათ.
Volume
286,21 ათ.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
345,30 მლნ.
Avg. vol.
785,30 ათ.
Volume
286,21 ათ.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
1 საათის წინ
S&P 500 Downward Gap Stocks in Nov. 20, 2026 Session
TradingView
·
48 წუთის წინ
S&P 500 is near a bottom, but breadth still shows final low is not there yet – BTIG’s Krinsky
Traders Union
·
21 წუთის წინ
S&P 500 P/E multiples range from 15.7x to 19.6x depending on EPS assumptions, Michael Kantro notes
FXEmpire
·
17 წუთის წინ
S&P 500 Price Forecast: AI Stock Selloff Puts 7,000 in Focus
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEOნიკოლაი სორენსენი
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com